Skip to main content
. 2019 May 17;55(5):161. doi: 10.3390/medicina55050161

Figure 1.

Figure 1

Radiograph images during the clinical course of idiopathic pulmonary fibrosis (IPF) for one year before the two years after initiation of pirfenidone treatment. Upper panel: reticular shadow on chest radiograph. Middle and lower panels: computed tomography (CT) images of influence of pirfenidone on IPF over a two-year period.